Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Sarcoma|April 26, 2018
Limb-Salvage Surgery of Soft Tissue Sarcoma with Sciatic Nerve InvolvementHussein Sweiti, Noor Tamimi, Fabian Bormann, et al.
Medical Oncology (Northwood, London, England)|April 29, 2009
Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinomaHolger Gerullis, Lothar Bergmann, Luise Maute, et al.
Aktuelle Urologie|December 1, 2021
[Interdisciplinary recommendations for the treatment of advanced renal cell carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2014
Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysisLuise Maute, Viktor Grünwald, Steffen Weikert, et al.
International Journal of Oncology|May 9, 2013
Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and ageMathias Hoiczyk, Florian Grabellus, Lars Podleska, et al.
Aktuelle Urologie|October 7, 2020
[Interdisciplinary recommendations for the treatment of advanced metastatic renal cell carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Future Oncology (London, England)|March 16, 2021
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registryArne Strauss, Marianne Schmid, Michael Rink, et al.
Experimental Hematology|March 31, 2004
CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cellsGabriele Hübinger, Christof Schneider, Dagmar Stöhr, et al.
Future Oncology (London, England)|October 6, 2020
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registryMartin Boegemann, Katrin Schlack, Michael Rink, et al.
Oncology Research and Treatment|January 19, 2022
A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)Viktor Grünwald, Thomas Hilser, Johannes Meiler, et al.
Pageof 7